The Drug Enforcement Administration extended certain COVID-19 era rules to allow healthcare providers to continue prescribing certain controlled substances via telehealth through the end of 2024, The Hill reported Oct. 6.
Read the full post on Becker's Hospital Review - Healthcare News
